17.09
0.70%
-0.12
Rigel Pharmaceuticals (RIGL) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
17.48%
29.53
|
35.79 | 28.13 | 26.89 | 26.07 |
Cost Of Revenue |
46.57%
2.025
|
3.79 | 1.268 | 1.075 | 0.977 |
Gross Profit |
14.04%
27.51
|
32.00 | 26.87 | 25.81 | 25.09 |
Operating Expenses
|
14.78%
34.48
|
30.04 | 31.33 | 31.08 | 37.82 |
Interest Income/Expense |
1.73%
1.874
|
1.907 | 1.899 | 1.862 | 1.204 |
Benefits Costs and Expenses |
7.78%
37.78
|
35.05 | 32.60 | 32.15 | 39.61 |
Costs And Expenses |
7.91%
36.50
|
33.83 | 32.60 | 32.15 | 38.80 |
Operating Income/Loss |
454.32%
-6.966
|
1.966 | -4.465 | -5.267 | -12.72 |
Income/Loss From Continuing Operations Before Tax |
1,219%
-8.247
|
0.737 | -4.465 | -6.60 | -13.54 |
Income/Loss From Continuing Operations After Tax |
1,219%
-8.247
|
0.737 | -5.692 | -6.60 | -13.54 |
Net Income/Loss
|
1,219%
-8.247
|
0.737 | -5.692 | -6.60 | -13.54 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
145.90K%
175.20
|
0.12 | 174.36 | 173.75 | 173.57 |
Diluted Average Shares |
145.90K%
175.20
|
0.12 | 174.36 | 173.75 | 173.57 |
Basic Earnings Per Share |
600.00%
-0.05
|
0.010 | -0.03 | -0.04 | -0.08 |
Diluted Earnings Per Share |
600.00%
-0.05
|
0.010 | -0.03 | -0.04 | -0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):